Posts in tag

CVD


‘Cholesterol complacency’ call to action For the first time in nearly a decade, new data highlights the potential extent of the cholesterol problem among high-risk patents costing the economy $1.5 …

Low-dose Xarelto has been listed on the PBS in combination with aspirin, for the prevention of major cardiovascular events in high-risk patients While pharmacists have been familiar with Xarelto (rivaroxaban) …

With men more likely than women to have their cardiovascular disease risk factors measured by their GP, can pharmacists help bridge the divide? Research from The George Institute for Global …

We take a look back at the last week in Australian pharmacy It’s been a tough week for the industry. This week, pharmacy was talking—again—about complementary medicines, following Four Corners‘ …

An article published by a doctor’s publication doesn’t tell the full story, says researcher A recent article in the Australian Doctor website called “Profit over patients? Concerns about pharmacy CV checks” …

Two Australian organisations will work together to develop a new four-in-one tablet, designed to reduce the impact of heart disease and stroke Bupa Australia and The George Institute for Global Health have …